scispace - formally typeset
C

Christopher J.H. Porter

Researcher at Monash University

Publications -  305
Citations -  22996

Christopher J.H. Porter is an academic researcher from Monash University. The author has contributed to research in topics: Lymphatic system & Bioavailability. The author has an hindex of 75, co-authored 286 publications receiving 20094 citations. Previous affiliations of Christopher J.H. Porter include Oak Ridge National Laboratory & University of British Columbia.

Papers
More filters
Journal ArticleDOI

Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs

TL;DR: The mechanisms by which lipids and lipidic excipients affect the oral absorption of lipophilic drugs are detailed and a perspective on the possible future applications of lipid-based delivery systems is provided.
Journal ArticleDOI

Strategies to Address Low Drug Solubility in Discovery and Development

TL;DR: The article provides an integrated and contemporary discussion of current approaches to solubility and dissolution enhancement but has been deliberately structured as a series of stand-alone sections to allow also directed access to a specific technology where required.
Journal ArticleDOI

Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.

TL;DR: The properties of excipients are discussed, the formulation strategies that can be used for each type of lipid formulation are outlined, and a framework for the in vitro testing of each type is suggested.
Journal ArticleDOI

Enhancing intestinal drug solubilisation using lipid-based delivery systems.

TL;DR: The mechanistic rationale which underpins the use of lipid-based delivery systems to enhance drug solubilisation is described and the available literature describing increases in oral bioavailability after the administration of lipid solution, suspension and self-emulsifying formulations is reviewed.
Journal ArticleDOI

Physicochemical and Physiological Mechanisms for the Effects of Food on Drug Absorption: The Role of Lipids and pH

TL;DR: Case studies are presented in which postprandial changes in bioavailability are rationalized in terms of the sensitivity of the physicochemical properties of the administered drug to the altered GI environment.